Listing of therapeutic products with paediatric information available in their labelling
The content on this page exceeds normal site dimensions due to the use of larger maps, tables, charts or other graphics.
Help on accessing alternative formats, such as Portable Document Format (
PDF
), Microsoft Word and PowerPoint (
PPT
) files, can be obtained in the
.
Contact for prescription pharmaceuticals, e-mail: Bureau of Cardiology, Allergy and Neurological Sciences (BCANS)
Contact for biologics and vaccines, e-mail: Office of Regulatory Affairs, Biologies and Genetic Therapies Directorate
| Brand Name | Medicinal Ingredient | Manufacturer | Pediatric Extension | Therapeutic Classification | Is it indicated in pediatrics? | Contra-indications | Warnings and Precautions | Adverse Reactions | Action and Clinical Pharma-cology | Clinical trials | Date of Revision | Control No. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaccines | ||||||||||||
| ACT-Hib | haemophilus b conjugate vaccine (tetanus protein-conjugate) | Sanofi Pasteur SA | No | Active Immunizing Agent | Yes (>2 months) | Yes | Yes | Yes | No | Yes | 2012-05-14 | 154297 |
| Adacel | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (> 4 years) | Yes | Yes | Yes | No | Yes | 2012-06-11 | 149843 |
| Adacel Polio | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed combined with inactivated poliomyelitis vaccine | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (>3 years) | Yes | Yes | Yes | No | Yes | 2013-07-02 | 165816 |
| Agriflu | influenza vaccine, surface antigen, inactivated) | Novartis Vaccines and Diagnostics Inc. | No | Active Immunizing Agent | Yes (>6 months) | Yes | Yes | Yes | No | Yes | 2014-05-07 | 174153 |
| Bexsero | recombinant neisseria meningitidis group B NHBA fusion protein, recombinant neisseria meningitidis group B NadA fusion protein, recombinant neisseria meningitidis group B fHBP fusion protein, outer membrane vesicle (neisseria meningitidis group B NZ98/254 strain) | Novartis Vaccines and Diagnostics Inc. | Yes | Active Immunizing Agent | Yes (from 2 month to 17 years) | Yes | Yes | Yes | Yes | Yes | 2013-12-06 | 147275 |
| Boostrix | combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>4 years) | Yes | Yes | Yes | No | Yes | 2013-08-15 | 166933 |
| Boostrix-Polio | combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>4 years) | Yes | Yes | Yes | No | Yes | 2011-07-12 | 147351 |
| Cervarix | recombinant human papillomavirus type 16 L1, type 18 L1 protein, AS04 adjuvant | GlaxoSmithKline Inc. | No | Active immunizing agent | Yes (>9 years) |
Yes | Yes | Yes | No | Yes | 2014-07-03 | 167022 |
| Engerix-B | hepatitis B vaccine (recombinant) | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes | Yes | Yes | Yes | No | Yes | 2013-08-09 | 165871 |
| Fluad | inflenza vaccine, surface antigen, inactivated, adjuvanted with MF59C.1 | Novartis Vaccines and Diagnostics Inc. | No | Active Immunizing Agent | No | Yes | Yes | Yes | Yes | Yes | 2014-05-07 | 174156 |
| FluMist | influenza vaccine, live, attenuated | AstraZeneca Canada Incorporated | Yes | Active Immunizing Agent | Yes (>2 years) | Yes | Yes | Yes | No | Yes | 2014-04-30 | 173815 |
| Fluviral | influenza virus vaccine, trivalent, split virion | ID Biomedical Corporation of Quebec | No | Active Immunizing Agent | Yes (>6 months) | Yes | Yes | Yes | No | Yes | 2014-07-08 | 175950 |
| Fluzone | influenza virus vaccine trivalent types A and B, split virion | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (>6 months) | Yes | Yes | Yes | No | Yes | 2014-09-04 | 177170 |
| Fluzone Quadrivalent | influenza virus vaccine quadrivalent types A and B (split virion) | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (>6 months) | Yes | Yes | Yes | No | Yes | 2014-04-30 | 173947 |
| Gardasil | recombinant human papillomavirus type 11 L1, type 16 L1, type 18 L1 & type 6 L1 protein | Merck Frosst Canada Ltd., | Yes | Active Immunizing Agent | Yes (>9 years) | Yes | Yes | Yes | No | Yes | 2014-05-15 | 163774 |
| Havrix | hepatitis A vaccine, inactivated | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>1 year) | Yes | Yes | Yes | No | Yes | 2011-07-12 | 147365 |
| Hiberix | haemophilus influenze type b (Hib) conjugate vaccine (tetanus protein-conjugate) | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>2 months) | Yes | Yes | Yes | No | Yes | 2013-04-25 | 163478 |
| Immucyst | bacillus calmette-Guérin (BCG), substrain Connaught | Sanofi Pasteur Limited | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2010-06-04 | 138821 |
| Imovax Polio | inactivated poliomyelitis vaccine (vero cell origin) | Sanofi Pasteur SA | No | Active Immunizing Agent | Yes (>2 months) | Yes | Yes | Yes | No | Yes | 2011-04-14 | 143808 |
| Imovax Rabies | rabies vaccine inactivated (DCO) | Sanofi Pasteur SA | No | Active Immunizing Agent | Yes | Yes | Yes | Yes | No | Yes | 2006-03-06 | 102730 |
| Infanrix Hexa | combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (6 weeks to 2 years) | Yes | Yes | Yes | No | Yes | 2014-07-31 | 174262 |
| Infanrix-IPV | Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (up to 6 years) | Yes | Yes | Yes | No | Yes | 2014-09-11 | 177364 |
| Infanrix-IPV/Hib | Combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, Haemophilus influenzae type b vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>6 weeks) | Yes | Yes | Yes | No | Yes | 2013-12-18 | 170025 |
| Influvac | influenza vaccine, surface antigen, inactivated) | Abbott Laboratories, Limited | No | Active Immunizing Agent | No | Yes | Yes | Yes | No | Yes | 2014-05-07 | 174264 |
| Intanza | influenza vaccine (split virion, inactivated) | Sanofi Pasteur SA | No | Active Immunizing Agent | No | Yes | Yes | Yes | No | Yes | 2013-04-13 | 163591 |
| Ixiaro | japanese encephalitis vaccine (inactivated, adsorbed) | Valneva Austria GmbH | No | Active Immunizing Agent | No | Yes | Yes | Yes | No | Yes | 2013-10-08 | 168092 |
| Menactra | meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (>9 months) | Yes | Yes | Yes | No | Yes | 2012-06-13 | 148493 |
| Meningitec | meningococcal serogroup C conjugate vaccine (diphtheria CRM197 protein) | Nuron Biotech B.V. | No | Active Immunizing Agent | Yes (>2 months) | Yes | Yes | Yes | No | Yes | 2013-11-13 | 168241 |
| Menjugate | meningococcal Group C-CRM197 conjugate vaccine | Novartis Vaccines and Diagnostics Inc. | No | Active Immunizing Agent | Yes (>2 months) | Yes | Yes | Yes | No | Yes | 2013-02-21 | 162131 |
| Menomune-A/C/Y/W-135 | meningococcal polysaccaride vaccine, groups A, C, Y and W-135 combined | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (>2 years) | Yes | Yes | Yes | No | Yes | 2013-07-30 | 151001 |
| Menveo | meningococal group a, c, w135 and y oligosaccharide CRM197 conjugate vaccine | Novartis Vaccines and Diagnostics Inc. | No | Active Immunizing Agent | Yes (>2 years) | Yes | Yes | Yes | No | Yes | 2013-03-13 | 156577 |
| M-M-R II | measles, mumps and rubella virus vaccine, live, attenuated, Merck Std | Merck Canada Inc. | No | Active Immunizing Agent | Yes (>12 months) | Yes | Yes | Yes | No | Yes | 2014-08-20 | 176262 |
| Nimenrix | meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>12 months) | Yes | Yes | Yes | No | Yes | 2014-09-18 | 169625 |
| Pediacel | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine AdsorbedCombined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate) |
Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (2 months to 6 years) | Yes | Yes | Yes | No | Yes | 2012-02-28 | 151711 |
| Pediarix | combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (2 months to 6 years) | Yes | Yes | Yes | No | Yes | 2011-07-12 | 147380 |
| Pentacel | haemophilus b conjugate vaccine (tetanus protein-conjugate) reconstituted with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed combined with inactivated poliomyelitis vaccine | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (2 months to 6 years) | Yes | Yes | Yes | No | Yes | 2012-01-30 | 151712 |
| Prevnar 13 | pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F | Pfizer Canada Inc. | Yes | Active Immunizing Agent | Yes (>6 weeks) | Yes | Yes | Yes | No | Yes | 2014-08-26 | 176388 |
| Priorix | measles, mumps and rubella virus vaccine, live, attenuated | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes | Yes | Yes | Yes | No | Yes | 2014-03-20 | 170834 |
| Priorix-Tetra | measles, mumps, rubella and varicella vaccine.live, attenuated | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (9months to 12 years) | Yes | Yes | Yes | No | Yes | 2013-04-03 | 163004 |
| Quadracel | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed combined with inactivated poliomyelitis vaccine | Sanofi Pasteur Limited | No | Active Immunizing Agent | Yes (2 months to 6 years) | Yes | Yes | Yes | No | Yes | 2011-08-04 | 146960 |
| Rotarix | rotavirus RIX4414 strain, live, attenuated (human) | GlaxoSmithKline Inc. | Yes | Active immunizing agent | Yes (>6 weeks) | Yes | Yes | Yes | No | Yes | 2014-02-21 | 170661 |
| Rotateq | rotavirus vaccine, live, oral type G1, type G2, type G3, type G4 & type P1(8) (human) | Merck Frosst Canada Ltd. | Yes | Active Immunizing Agent | Yes (between 6 weeks and 32 weeks) | Yes | Yes | Yes | No | Yes | 2013-08-02 | 166675 |
| Synflorix | pneumococcal polysaccharide serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F | GlaxoSmithKline Inc. | Yes | Active immunizing agent | Yes (from 6 weeks to 5 years) | Yes | Yes | Yes | No | Yes | 2014-08-26 | 176097 |
| Typherix | salmonalla typhi Vi capsular polysaccharide vaccine | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>2 years) | Yes | Yes | Yes | No | Yes | 2014-02-10 | 171120 |
| Twinrix | hepatitis A vaccine, inactivated, hepatitis B surface antigen (recombinant) | GlaxoSmithKline Inc. | No | Active Immunizing Agent | No | Yes | Yes | Yes | No | Yes | 2013-08-15 | 166932 |
| Twinrix Junior | hepatitis A vaccine, inactivated, hepatitis B surface antigen (recombinant) | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes | Yes | Yes | Yes | No | Yes | 2013-08-15 | 166932 |
| Varilrix | varicella virus vaccine, live, attendated [Oka-strain] | GlaxoSmithKline Inc. | No | Active Immunizing Agent | Yes (>12 months) | Yes | Yes | Yes | No | Yes | 2014-03-20 | 170835 |
| Varivax III | varicella virus vaccine, live, attendated [Oka/Merck] | Merck Canada Inc. | No | Active Immunizing Agent | Yes (>12 months) | Yes | Yes | Yes | No | Yes | 2014-03-03 | 169513 |
| Vaxigrip | inactivated influenza vaccine trivalent types A and B (split virion) | Sanofi Pasteur SA | No | Active Immunizing Agent | Yes (>6 months) | Yes | Yes | Yes | No | Yes | 2014-04-30 | 173380 |
| Zostavax and Zostavax II | zoster vaccine live, attenuated [Oka/Merck] | Marck Canada Inc. | No | Active Immunizing Agent | No | Yes | Yes | Yes | No | Yes | 2014-07-25 | 176177 |
| Other biologics | ||||||||||||
| Actemra | tocilizumab | Hoffmann-La Roche Ltd. | Yes | Interleukin Receptor Inhibitor | Yes (>2 years for Polyarticular Juvenile Idiopathic Arthritis and Systemic Juvenile Idiopathic Arthritis [IV Formulation only]) | Yes | Yes | Yes | Yes | Yes | 2014-08-15 | 175429 |
| Advate | antihemophilic factor (recombinant) | Baxter Healthcare Corporation | No | Coagulant | Yes | Yes | Yes | Yes | Yes | Yes | 2013-12-19 | 169522 |
| Albumin (Human) 5% Solution | albumin (human) 5%, USP | Grifols Therapeutics Inc. | No | Plasma Substitute / Blood Derivative | Yes | Yes | Yes | Yes | No | Yes | 2009-01-19 | 125734 |
| Allergenic Extracts - Standardized Grass Pollen Extracts | Standardized Timothy Grass Standardized Orchard Grass Standardized June Grass Standardized Redtop Standardized Sweet Vernal Standardized Perennial Rye Grass Standardized Meadow Fescue Grass Mix of 4 Standardized Grasses (Timothy, Orchard, June, Redtop) Mix of 5 Standardized Grasses (Timothy, Orchard, June, Redtop, Sweet Vernal) |
ALK-Abelló | No | Immuno-therapy | Yes | Yes | Yes | Yes | No | N/A | 2009-05-08 | 123862 |
| Antithrombin III NF | antithrombin III (human), EP | Baxter AG | No | anticoagulant | Yes | Yes | Yes | Yes | Yes | No | 2013-05-06 | 163578 |
| Apidra | insulin glulisine (rDNA origin) | sanofi-aventis Canada Inc. | No | Antidiabetic Agent | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2014-02-11 | 170532 |
| Arzerra | ofatumumab | GlaxoSmithKline Inc. | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2013-05-10 | 154481 |
| Artiss | fibin sealant (human), vapor heated, solvent detergent treated) | Baxter AG | No | Hemostatic Agent | Yes | Yes | Yes | Yes | N/A | Yes | 2013-12-19 | 161304 |
| Avastin | bevacizumab | Hoffmann-La Roche Limited | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2014-06-27 | 173339 |
| Benefix | coagulation factor IX (recombinant) | Pfizer Canada Inc. | No | Antihemorrhagic Blood Coagulation Factor IX | Yes | Yes | Yes | Yes | Yes | Yes | 2012-12-27 | 153056 |
| Benlysta | balimumab | GlaxoSmithKline Inc. | No | Immuno-suppressant | No | Yes | Yes | Yes | Yes | Yes | 2014-04-16 | 171362 |
| Berinert | C1 esterase inhibitor (human) | CSL Behring Canada Inc | No | Human C1 Esterase Inhibitor | No | Yes | Yes | Yes | Yes | Yes | 2014-05-02 | 174181 |
| Betaseron | interferon beta-1b | Bayer Inc | No | Immuno-modulator | No | Yes | Yes | Yes | Yes | Yes | 2011-07-11 | 133528 |
| Botox | onabotulinumtoxinA | Allergan, Inc. | No | Neuromuscular Paralytic Agent | Yes (>12 years for Blepharospasm and Strabismus and >2 years for Equinus Foot) | Yes | Yes | Yes | Yes | Yes | 2013-05-23 | 163891 |
| Elaprase | idursulfase | Shire Human Genetic Therapies, Inc. | Yes | Enzyme Replacement Therapy | Yes |
Yes | Yes | Yes | Yes | Yes | 2014-02-21 | 168295 |
| Enbrel | etanercept | Immunex Corporation | No | Biological Response Modifier | Yes (>4 years for polyarticular juvenile idiopathic arthritis) | Yes | Yes | Yes | Yes | Yes | 2013-09-13 | 165423 |
| Eprex | epoetin alfa | Janssen Inc. | No | Erythropoiesis Regulating Hormone | Yes (>1 month for anemia related to chronic renal failure) | Yes | Yes | Yes | Yes | Yes | 2011-10-14 | 145519 |
| Erbitux | cetuximab | ImClone LLC | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2014-01-14 | 168870 |
| Evicel | fibrin sealant kit | Omrix Biopharmaceuticals Inc. | No | Haemostatic Agent | No | Yes | Yes | Yes | Yes | Yes | 2013-08-16 | 164920 |
| Fabrazyme | agalsidase beta | Genzyme Canada Inc. | No | Enzyme Replacement Therapy | Yes (>8 years) | Yes | Yes | Yes | Yes | Yes | 2011-04-07 | 131220 |
| Forteo | teriparatide (rDNA origin) injection | Eli Lilly Canada Inc. | No | Bone Formation Agent | No | Yes | Yes | Yes | Yes | Yes | 2010-02-09 | 128554 |
| Fragmin | dalteparin sodium | Pfizer Canada Inc. | No | Anticoagulant / Antithrombotic Agent | No | Yes | Yes | Yes | Yes | Yes | 2014-09-02 | 174567 |
| Fraxiparine, Fraxiparine Forte | nadroparin calcium | GlaxoSmithKline Inc. | No | Anticoagulant / Antithrombotic Agent | No | Yes | Yes | Yes | Yes | Yes | 2014-06-30 | 173407 |
| Gammagard Liquid | immune globulin (human) | Baxter Corporation | No | Replacement Therapy for Immuno-deficienies | Yes (>24 months) | Yes | Yes | Yes | Yes | Yes | 2014-09-04 | 175223 |
| Gammagard S/D | immune globulin (human) | Baxter Corporation | No | Replacement Therapy for Immuno-deficienies | Yes (>24 months) | Yes | Yes | Yes | Yes | Yes | 2014-08-27 | 175228 |
| Gamunex | immune globulin (human) | Grifols Therapeutics Inc. | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2014-07-21 | 175423 |
| Gonal-F | follitropin alpha for injection | EMD Serono A Division of EMD Inc Canada | No | Gonadotropin | No | Yes | Yes | Yes | Yes | Yes | 2013-03-21 | 143068 |
| Grastek | standardized allergenic extract, Timothy Grass (Phleum pratense) | Merck Canada Inc. | No | Immuno-therapy | Yes (>5 years) | Yes | Yes | Yes | Yes | Yes | 2013-12-12 | 148335 |
| Helixate FS | antihemophilic factor (recombinant) | Bayer Inc | No | Coagulation Factor | Yes | Yes | Yes | Yes | Yes | Yes | 2014-07-04 | 175403 |
| Hepagam B | hepatitis B immune globulin (human) | Cangene Corporation dba Emergent Biosolutions | No | Passive Immunizing Agent | Yes (post-exposure prophylaxis) | Yes | Yes | Yes | Yes | Yes | 2012-11-26 | 158139 |
| Hizentra | subcutaneous immune globulin (human) | CSL Behring Canada Inc | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2014-09-04 | 175108 |
| Humalog | insulin lispro | Eli Lilly Canada Inc. | No | Anti-diabetic Agent | Yes (>3 years) | Yes | Yes | Yes | Yes | Yes | 2012-06-08 | 154924 |
| Humalog MIX25, Humalog MIX50 | insulin lispro, insulin lispro protamine suspension | Eli Lilly Canada Inc. | No | Anti-diabetic Agent | No | Yes | Yes | Yes | Yes | Yes | 2012-06-08 | 154924 |
| Humate-P | antihemophilic factor / von Willebrand factor complex (human) | CSL Behring Canada Inc | No | Coagulation Factor | Yes (von Willebrand's Disease and prevention of bleeding during and after surgery) | No | Yes | Yes | No | Yes | 2014-03-11 | 170453 |
| Humatrope | somatropin | Eli Lilly Canada Inc. | No | Growth Stimulant | Yes | Yes | Yes | Yes | No | Yes | 2013-08-19 | 165627 |
| Humira | adalimumab | Abbvie Corporation | No | Biological Response Modifier | Yes (>4 years for Polyarticular JIA and >13 years for Pediatric Crohn's Disease) | Yes | Yes | Yes | Yes | Yes | 2014-01-17 | 169101 |
| Humulin R | insulin, human biosynthetic | Eli Lilly Canada Inc. | No | Anti-diabetic Agent | Yes | Yes | Yes | Yes | No | Yes | 2013-10-22 | 167827 |
| Humulin N | insulin isophane, human biosynthetic, rDNA origin | Eli Lilly Canada Inc. | No | Anti-diabetic Agent | Yes | Yes | Yes | Yes | No | Yes | 2013-10-22 | 167827 |
| Humulin 30/70 | 30% insulin injection, 70% insulin isophane, human biosynthetic, rDNA origin | Eli Lilly Canada Inc. | No | Anti-diabetic Agent | Yes | Yes | Yes | Yes | No | Yes | 2013-10-22 | 167827 |
| HyperHep B S/D | hepatitis B immune globulin (human) | Grifols Therapeutics Inc. | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes (included but info on PK study with rabies immune globulin) | Yes | 2012-02-02 | 152142 |
| HyperRab S/D | rabies immune globulin (human) | Grifols Therapeutics Inc. | No | Passive Immunizing Agent | Yes | No | Yes | Yes | No | No | 2012-01-30 | 152140 |
| HyperRho S/D | Rho(D) immune globulin (human) | Grifols Therapeutics Inc. | No | Passive Immunizing Agent | No | Yes | Yes | Yes | Yes (included but info on PK study with rabies immune globulin) | No | 2012-02-20 | 152143 |
| HyperTet S/D | tetanus immune globulin (human) | Grifols Therapeutics Inc. | No | Passive Immunizing Agent | Yes | No | Yes | Yes | No | No | 2013-02-03 | 152494 |
| Ilaris | canakinumab | Novartis Pharmaceuticals Canada Inc. | Yes | Immuno-modulatory Agent | Yes (>2 years) | Yes | Yes | Yes | Yes | Yes | 2014-07-14 | 174258 |
| Immune Serum Globulin (Human) | immune globulin (human) | Grifols Therapeutics Inc. | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes (included but info on PK study with rabies immune globulin) | Yes | 2014-07-21 | 175382 |
| Imogam Rabies | rabies immune globulin (human) | Sanofi Pasteur SA | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2005-10-24 | 101760 |
| Inflectra | infliximab | Hospira Healthcare Corporation | No | Biological Response Modifier | No | Yes | Yes | Yes | Yes | Yes | 2014-06-04 | 173846 |
| Innohep | tinzaparin sodium | Leo Pharma Inc. | No | Anticoagulant / Antithrombotic Agent | No | Yes | Yes | Yes | Yes | Yes | 2014-08-07 | 174818 |
| Kadcyla | trastuzumab emtansine | Hoffmann-La Roche Limited | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2013-09-11 | 162414 |
| Kepivance | palifermin | Swedish Orphan Biovitrum AB | No | Keratinocyte Growth Factor | No | Yes | Yes | Yes | Yes | Yes | 2013-12-19 | 169141 |
| Kineret | anakinra | Swedish Orphan Biovitrum AB | No | Immuno-modulatory Agent | No | Yes | Yes | Yes | Yes | Yes | 2013-05-28 | 162969 |
| Kogenate FS | antihemophilic factor (recombinant) | Bayer Inc | No | Coagulation Factor | Yes | Yes | Yes | Yes | Yes | Yes | 2014-05-30 | 159265 |
| Lemtrada | alemtuzumab | Genzyme Canada, a division of sanofi-aventis Canada Inc. | No | Selective Immuno-modulator | No | Yes | Yes | Yes | Yes | Yes | 2013-12-12 | 161152 |
| Levemir | insulin detemir | Novo Nordisk Canada Inc. | No | Antidiabetic Agent | Yes (>2 years) |
Yes | Yes | Yes | Yes | Yes | 2013-12-19 | 161408 |
| Lovenox | enoxaparin sodium | sanofi-aventis Canada Inc. | No | Anticoagulant / Antithrombotic Agent | No | Yes | Yes | Yes | Yes | Yes | 2014-07-07 | 174576 |
| Myozyme | alglucosidase alfa | Genzyme Canada Inc. | Yes | Enzyme Replacement Therapy | Yes (>1 month) | Yes | Yes | Yes | Yes | Yes | 2014-06-09 | 173862 |
| Naglazyme | galsulfase | BioMarin Pharmaceutical Inc. | Yes | Enzyme Replacement Therapy | Yes (>1 year) | Yes | Yes | Yes | Yes | Yes | 2013-09-16 | 159020 |
| Neulasta | pegfilgrastim | Amgen Canada Inc. | No | hematopoietic agent Granulocyte Colony-Stimulating Factor |
No | Yes | Yes | Yes | Yes | Yes | 2014-03-21 | 170753 |
| Neupogen | filgrastim | Amgen Canada Inc. | No | hematopoietic agent Granulocyte Colony-Stimulating Factor |
Yes | Yes | Yes | Yes | Yes | Yes | 2014-03-21 | 170755 |
| Niastase RT | eptacog alfa | Novo Nordisk Canada Inc. | No | Coagulation Factor | Yes | Yes | Yes | Yes | Yes | Yes | 2014-04-10 | 171508 |
| Novomix 30 | soluble insulin aspart, insulin aspart protamine crystals | Novo Nordisk Canada Inc. | No | Anti-diabetic Agent | Yes (>16 years) | Yes | Yes | Yes | Yes | Yes | 2014-08-20 | 175375 |
| Nplate | romiplostim | Amgen Canada Inc. | Yes | Thrombopoiesis-Stimulating Protein | No | Yes | Yes | Yes | Yes | Yes | 2014-02-06 | 162650 |
| Nutropin AQ | somatropin | Hoffmann-La Roche Limited | No | Growth Hormone | Yes | Yes | Yes | Yes | Yes | Yes | 2014-05-01 | 172192 |
| Octagam 5% | immune globulin (human) | Octapharma pharmazeutika produktionsges M B H | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2014-09-11 | 177147 |
| Oralair | grass pollen allergen extract | Paladin Labs Inc | No | Allergenic Substance | Yes (>5 years) |
Yes | Yes | Yes | No | Yes | 2012-03-15 | 146210 |
| Orencia | abatacept | Bristol-Myers Squibb Canada | Yes | Selective Co-stimulation Modulator | Yes (>6 years) | Yes | Yes | Yes | Yes | Yes | 2013-10-07 | 166203 |
| Ovidrel | choriogonadotropin alpha | EMD Serono A Division of EMD Inc Canada | No | Gonadotropin | No | Yes | Yes | Yes | Yes | Yes | 2012-09-07 | 156156 |
| Pegasys | peginterferon alfa-2a | Hoffmann-La Roche Limited | No | Biological Response Modifier | No | Yes | Yes | Yes | Yes | Yes | 2014-02-10 | 162772 |
| Pegasys RBV | peginterferon alfa-2a ribavirin |
Hoffmann-La Roche Limited | No | Antiviral Agent | No | Yes | Yes | Yes | Yes | Yes | 2014-02-10 | 162775 |
| Perjeta | pertuzumab | Hoffmann-La Roche Limited | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2014-03-05 | 170371 |
| Pulmozyme | dornase alfa | Hoffmann-La Roche Limited | No | An enzyme that cleaves DNA | Yes (>5 years) |
Yes | Yes | Yes | Yes | Yes | 2006-08-15 | 091949 |
| Privigen | immune globulin (human) | CSL Behring Canada Inc | No | Passive Immunizing Agent | Yes (>3 years for PID and >15 for ITP) | Yes | Yes | Yes | Yes | Yes | 2014-06-17 | 175008 |
| Prolia | denosumab | Amgen Canada Inc. | No | Bone Metabolism Regulator | No | Yes | Yes | Yes | Yes | Yes | 2014-06-16 | 173498 |
| Rebif | interferon beta-1a | EMD Serono A Division of EMD Inc Canada | No | Immuno-modulator | Yes | Yes | Yes | Yes | Yes | Yes | 2014-07-09 | 174259 |
| Remsima | infliximab | Celltrion Healthcare Co. Ltd | No | Biological Response Modifier | No | Yes | Yes | Yes | Yes | Yes | 2014-01-15 | 160195 |
| Reopro | abciximab | Janssen Biotech, Inc. | No | Chimeric Monoclonal Antiplatelet Antibody | No | Yes | Yes | Yes | Yes | Yes | 2014-07-10 | 175368 |
| Riastap | fibrinogen concentrate (human), FCH | CSL Behring Canada Inc | No | Fibrinogen, human | Yes | Yes | Yes | Yes | Yes | Yes | 2014-05-29 | 174777 |
| Simponi | golimumab | Janssen Inc. | No | Tumour Necrosis Factor Alpha inhibitor | No | Yes | Yes | Yes | Yes | Yes | 2014-05-15 | 173283 |
| Simulect | basiliximab | Novartis Pharmaceuticals Canada Inc. | No | Immuno-suppressant | No | Yes | Yes | Yes | Yes | Yes | 2014-07-18 | 173177 |
| Soliris | eculizumab | Alexion Pharmaceuticals, Inc. (now Alexion Pharma International Sàrl) | Yes | Humanized Monoclonal Antibody | Yes (less than 13 years for atypical Hemolytic Uremic Syndrome [NOC/c] and 13-17 years for atypical Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria [NOC]) |
Yes | Yes | Yes | Yes | Yes | 2013-05-31 | 163831 |
| Thymoglobulin | anti-thymocyte globulin (rabbit) | sanofi-aventis Canada Inc. | No | Immuno-suppressant | No | Yes | Yes | Yes | Yes | Yes | 2013-05-06 | 163590 |
| Tretten | catridecacog (recombinant coagulation factor XIII A-Subunit) | Novo Nordisk Canada Inc. | Yes | Coagulation Factor | Yes | Yes | Yes | Yes | Yes | Yes | 2014-05-20 | 165552 |
| Vectibix | panitumumab | Amgen Canada Inc. | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2014-06-04 | 173379 |
| Victoza | liraglutide | Novo Nordisk Canada Inc. | No | Human Glucagon Like Peptide-1 (GLP-1) | No | Yes | Yes | Yes | Yes | Yes | 2014-07-23 | 175595 |
| Vimizim | elosulfase alfa | BioMarin International Limited | No | Enzyme Replacement Therapy | Yes (>5 years) | Yes | Yes | Yes | Yes | Yes | 2014-07-02 | 170340 |
| Vivaglobin | immunoglobin G (human) | ZLB Behring Canada Inc | No | Passive Immunizing Agent | Yes (>2 years) |
Yes | Yes | Yes | Yes | Yes | 2011-01-20 | 143341 |
| Vpriv | velaglucerase alfa | Shire Human Genetic Therapies, Inc. | Yes | Enzyme Replacement Therapy | Yes | Yes | Yes | Yes | Yes | Yes | 2011-08-12 | 132604 |
| Xeomin | incobotulinumtoxin A | Merz Pharmaceuticals GmbH | No | Muscle relaxant, peripherally acting agent | No | Yes | Yes | Yes | Yes | Yes | 2013-06-28 | 165909 |
| Xeomin Cosmetic | incobotulinumtoxin A | Merz Pharmaceuticals GmbH | No | Muscle relaxant, peripherally acting agent | No | Yes | Yes | Yes | Yes | Yes | 2013-07-04 | 165989 |
| Xgeva | denosumab | Amgen Canada Inc. | No | Bone Metabolism Regulator | Yes (>13 years for skeletally mature adolescents with giant cell tumour of bone) | Yes | Yes | Yes | Yes | Yes | 2014-02-05 | 169537 |
| Xyntha | moroctog alfa [BDD-rFVIII] | Pfizer Canada Inc. | No | Antihemorrhagic Blood Coagulation Factor VIII | Yes | Yes | Yes | Yes | Yes | Yes | 2013-07-10 | 164015 |
| Wilate | antihemophilic factor (human), human plasma proteins, von willebrand factor (human) | Octapharma pharmazeutika produktionsges M B H | No | Human von Willebrand factor (VWF) and human Coagulation Factor VIII (FVIII) | Yes (>12 years) | Yes | Yes | Yes | Yes | Yes | 2012-01-12 | 150722 |
| WINRHO SDF | Rho(D) immune globulin (human) | Cangene Corporation dba Emergent Biosolutions | No | Passive Immunizing Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2010-12-23 | 140834 |
| Yervoy | ipilimumab | Bristol-Myers Squibb Canada | No | Antineoplastic | No | Yes | Yes | Yes | Yes | Yes | 2014-04-28 | 171870 |
| Pharmaceuticals | ||||||||||||
| Abilify | aripiprazole | Bristol-Myers Squibb Canada / Otsuka Pharmaceutical Co. Ltd. | Yes | Antipsychotic agent | Yes (ages 15-17 for schizophrenia and 13-17 for bipolar disorder) |
Yes | Yes | Yes | No | Yes | 2013-05-27 | 156496 |
| Adderall XR | mixed salts amphetamine | Shire Canada Inc. | No | Central Nervous System Stimulant | Yes (>6 years) | Yes | Yes | Yes | Yes | Yes | 2014-05-12 | 171971 |
| Advagraf | tacrolimus | Astellas Pharma Canada, Inc. | No | Immuno-suppressant | No | No | Yes | No | Yes | Yes | 2014-04-16 | 165402 |
| Afinitor | everolimus | Novartis Pharmaceuticals Canada Inc. | Yes | Antineoplastic agent | Yes (>1 year for SEGA) | Yes | Yes | Yes | Yes | Yes | 2014-05-28 | 158464 |
| Airomir | salbutamol sulfate | Valeant Canada LP | No | Bronchodilator; B2-adrenergic stimulant | Yes (>6 years) | Yes | Yes | No | No | Yes | 2014-07-04 | 174211 |
| Alvesco | ciclesonide | Nycomed Canada Inc. (now Takeda Canada Inc.) | Yes | Corticosteroid for oral inhalation | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2012-06-25 | 155860 |
| Anafranil | Clomipramine hydrochloride | Sunovion Pharmaceuticals Canada Inc. | No | Antiobsessional | Yes (>10 years) | Yes | Yes | No | No | N/A | 2012-06-07 | 155890 |
| Asmanex Twisthaler | mometasone furoate | Merck Canada Inc. | No | Corticosteroid | Yes (>12 years) | Yes | Yes | Yes | No | No | 2013-08-20 | 158226 |
| Atriance | nelarabine | GlaxoSmithKline Inc. | Yes | Antineoplastic Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2012-03-16 | 152058 |
| Avamys | fluticasone furoate | GlaxoSmithKline Inc. | Yes | Corticosteroid for nasal use | Yes (>2 years) | Yes | Yes | Yes | Yes | Yes | 2013-10-21 | 166602 |
| Banzel | rufinamide | Eisai Limited | Yes | Antiepileptic | Yes (>4 years) | Yes | Yes | Yes | Yes | Yes | 2011-11-28 | 150007 |
| Besivance | besifloxacin | Bausch & Lomb Inc. | Yes | Antibacterial (ophthalmic) | Yes (>1 year) | Yes | Yes | Yes | No | Yes | 2009-10-23 | 165608 |
| Biacna Topical Gel | tretinoin, clindamycin phosphate | Valeant Canada Limited | No | Acne Therapy | Yes (>12 years) |
Yes | Yes | Yes | No | Yes | 2010-11-29 | 130385 |
| Biphentin | methylphenidate hydrochloride | Purdue Pharma | No | Central Nervous System Stimulant | Yes (>6 years) | Yes | Yes | Yes | Yes | N/A | 2012-11-23 | 158412 |
| Busulfex | busulfan | Otsuka Pharmaceutical Co LTD | No | Antineoplastic | Yes (>5 months) | Yes | Yes | Yes | No | Yes | 2012-01-20 | 151613 |
| Cancidas | caspofungin acetate | Merck Frosst Canada LTD | No | Antifungal | Yes (>12 months) | Yes | Yes | Yes | Yes | Yes | 2013-02-21 | 160409 |
| Carbolith | lithium carbonate | Valeant Canada LP | No | Antimanic Agent | Yes (>12 years) | Yes | Yes | No | No | N/A | 2013-09-10 | 166365 |
| Cerebyx | fosphenytoin | ERFA Canada 2012 Inc. | No | Antiepileptic Agent | No | No | No | No | Yes | No | 2013-08-20 | 165006 |
| Champix | varenicline tartrate | Pfizer Canada Inc. | Yes | Smoking-Cessation Aid | No | No | No | No | Yes | No | 2014-03-03 | 170314 |
| Clolar | clofarabine | Genzyme Canada Inc. (now sanofi aventis Canada Inc.) | Yes | Antineoplastic agent | Yes (pediatric patients from 1-21 years) | Yes | Yes | Yes | Yes | Yes | 2013-04-22 | 163587 |
| Concerta | methylphenidate hydrochloride | Janssen Inc | No | Central Nervous System Stimulant | Yes (>6 years) | Yes | Yes | Yes | Yes | Yes | 2014-07-23 | 174166 |
| Cozaar | losartan potassium | Merck Frosst Canada LTD | No | Angiotensin II Receptor Antagonist | Yes (>6 years) | Yes | Yes | No | Yes | Yes | 2013-03-27 | 161159 |
| Crestor | rosuvastatin calcium | AstraZeneca Canada Incorporated | No | Lipid Metabolism Regulator | Yes (>10 years) | Yes | Yes | Yes | Yes | Yes | 2013-05-01 | 162673 |
| Cubicin | daptomycin | Cubist Pharmaceuticals, Incorporated | Yes | Antibacterial agent | No | No | No | No | Yes | No | 2013-08-09 | 158687 |
| Cyanokit | hydroxocobalamin | EMD Serono A Division of EMD Inc Canada | No | Antidote | Yes | N/A | No | No | No | Yes | 2014-03-14 | 168287 |
| Cymbalta | duloxetine hydrochloride | Eli Lilly Canada Inc. | Yes | Analgesic / Antidepressant / Anxiolytic | No | No | Yes | No | Yes | No | 2014-05-07 | 172212 |
| Cystadane | betaine anhydrous | Orphan Europe Sarl | No | Anti-Homocysteine Agent | Yes | Yes | Yes | No | No | N/A | 2010-04-27 | 137524 |
| Definity | perflutren | Lantheus MI Canada Inc | No | Contrast Enhancing Imaging Agent | Yes (>16 years) | Yes | Yes | No | No | No | 2011-10-13 | 142757 |
| Depakene | valproic acid | Abbott Laboratories, Limited | No | Antiepileptic | Yes | Yes | Yes | Yes | Yes | N/A | 2013-11-06 | 167619 |
| Dexedrine | dextroamphetamine sulfate | Paladin Labs Inc. | No | Sympatho-mimetic | Yes (>6 years) | Yes | Yes | No | N/A | N/A | 2009-02-02 | 127564 & 127565 |
| Diacomit | stiripentol | Biocodex SA | Yes | Antiepileptic | Yes (>3 years) |
Yes | Yes | Yes | Yes | Yes | 2012-12-19 | 142417 |
| Diastat | diazepam | Valeant Pharmaceuticals International | No | Anticonvulsant | Yes (>2 years) | Yes | Yes | Yes | Yes | Yes | 2005-05-13 | 098579 |
| Diazemuls | diazepam | Actavis Group PTC | No | Anxiolytic-sedative | Yes (>30 days) | Yes | Yes | No | No | N/A | 2007-02-20 | 112040 |
| Dilantin | phenytoin | Pfizer Canada Inc | No | Anticonvulsant | Yes | Yes | Yes | No | No | N/A | 2013-07-22 | 164100 |
| Durezol | difluprednate | Alcon Canada Inc. | Yes | Topical corticosteroid | Yes (>3 years) |
Yes | Yes | Yes | Yes | Yes | 2013-11-01 | 154517 |
| Eloxatin | oxaliplatin | sanofi-aventis Canada Inc. | Yes | Antineoplastic Agent | No | No | Yes | No | No | No | 2013-07-30 | 164367 |
| Epival | valproic acid | Abbott Laboratories, Limited | No | Antiepileptic | Yes (for epilepsy) |
Yes | Yes | Yes | Yes | Yes | 2013-11-06 | 167615 |
| Eraxis | anidulafungin | Pfizer Canada Inc. | Yes | Antifungal agent | No | No | No | No | Yes | Yes | 2012-04-30 | 153866 |
| Exjade | deferasirox | Novartis Pharmaceuticals Canada Inc. | Yes | Iron chelating agent | Yes (>6 years in patients with transfusion-dependent anemias, 2-5 years for those who cannot be treated with deferoxamine, >10 years in patients with non-transfusion-dependent thalassemia syndromes) | Yes | Yes | Yes | No | Yes | 2013-10-17 | 166844 |
| Frisium | clobazam | Lundbeck Inc. | No | Anticonvulsant | Yes | Yes | Yes | Yes | No | N/A | 2011-12-09 | 149753 |
| Fycompa | perampanel | Eisai Limited | Yes | Antiepileptic Agent | No | No | No | No | Yes | No | 2013-04-03 | 153747 |
| Gadovist 1.0 | Gadobutrol | Bayer Inc | No | Contrast Enhancement Agent for Magnetic Resonance Imaging (MRI) |
Yes (>2 years) | Yes | Yes | Yes | Yes | Yes | 2014-03-04 | 164061 |
| Inspra | eplerenone | Pfizer Canada Inc. | Yes | Aldosterone antagonist | No | No | No | No | Yes | No | 2012-08-21 | 151164 |
| Intelence | etravirine | Janssen Inc. | Yes | Human Immuno-deficiency Virus (HIV) non-nucleoside reverse transcriptase inhibitor | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2013-05-10 | 162869 |
| Intuniv XR | guanfacine hydrochloride | Shire Canada Inc. | Yes | selective alpha 2A-adrenergic receptor agonist | Yes (pediatric patients from 6-12 years) | Yes | Yes | Yes | Yes | Yes | 2013-07-04 | 150741 |
| Invanz | ertapenem sodium | Merck Frosst Canada LTD | No | Antibiotic | Yes (>3 months) | Yes | Yes | Yes | Yes | Yes | 2013-12-09 | 167780 |
| Invega | paliperidone | Janssen-Ortho Inc. (now Janssen Inc.) | Yes | Antipsychotic Agent | No | No | Yes | Yes | No | No | 2013-10-23 | 166513 |
| Invega Sustenna | paliperidone palmitate | Janssen-Ortho Inc. (now Janssen Inc.) | Yes | Antipsychotic Agent | No | No | Yes | No | No | No | 2014-04-08 | 171593 |
| Isentress | raltegravir potassium | Merck Frosst Canada Inc. | Yes | Human immuno-deficiency virus integrase strand transfer inhibitor | Yes (>2 years) |
Yes | Yes | Yes | Yes | Yes | 2014-03-06 | 171329 |
| Kalydeco | ivacaftor | Vertex Pharmaceuticals (Canada) Inc. | Yes | Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2014-06-04 | 170267 |
| Keppra | levetiracetam | UCB Canada Inc. | No | Antiepileptic Agent | No | No | Yes | No | Yes | No | 2014-03-05 | 170491 |
| Kuvan | sapropterin dihydrochloride | BioMarin Pharmaceutical Inc. | Yes | Enzyme Activator | Yes (>4 years) |
Yes | Yes | Yes | Yes | Yes | 2010-04-28 | 128151 |
| Lamictal | lamotrigine | GlaxoSmithKline Inc. | No | Antiepileptic | Yes (for Lennox-Gastaut syndrome) | Yes | Yes | Yes | Yes | Yes | 2014-06-24 | 173417 |
| Lescol, Lescol XL | fluvastatin | Novartis Pharmaceuticals Canada Inc. | No | Lipid Metabolism Regulator | Yes (>10 years) | Yes | Yes | Yes | No | Yes | 2013-09-11 | 156799 |
| Lipidil Supra/EZ/ micro | fenofibrate | Laboratories Fournier S.C.A. | No | Lipid Metabolism Regulator | No | Yes | No | No | No | No | 2013-09-05 | 165706 |
| Lipitor | atorvastatin calcium | Pfizer Canada Inc. | No | Lipid Metabolism Regulator | Yes (>10 years) | Yes | Yes | Yes | Yes | Yes | 2013-05-29 | 163180 |
| Lithane | lithium carbonate | ERFA Canada 2012 Inc. | No | Antimanic Agent | Yes (>12 years) | Yes | Yes | No | No | N/A | 2013-09-10 | 166340 |
| Lorazepam Injection USP | lorazepam | Hospira Healthcare Corporation | No | Anxiolytic - Sedative | No | No | Yes | Yes | No | N/A | 2012-06-27 | 152520 |
| Malarone Pediatric | atovaquone, proguanil hydrochloride | GlaxoSmithKline Inc. | No | Antimalarial Agent | Yes (>3 years) |
Yes | Yes | Yes | Yes | Yes | 2012-06-15 | 154259 |
| Maxalt, Maxalt RPD | rizatriptan benzoate | Merck Canada Inc. | No | Migraine Therapy | No | No | Yes | Yes | Yes | Yes | 2013-05-08 | 151004 |
| Mycamine | micafungin sodium | Astellas Pharma Canada, Inc. | No | Antifungal | Yes (>4 months) | Yes | Yes | Yes | Yes | Yes | 2014-03-24 | 163602 |
| Neurontin | gabapentin | Pfizer Canada Inc. | No | Antiepileptic Agent | No | No | Yes | No | No | Yes | 2013-12-30 | 168959 |
| Nexium | esomeprazole | AstraZeneca Canada Incorporated | No | H+, K+-ATPase Inhibitor | Yes (>1 year) | Yes | Yes | Yes | Yes | Yes | 2013-08-29 | 165397 |
| Norvasc | amlodipine besylate | Pfizer Canada Inc. | No | Antihypertensive-Antianginal Agent | Yes (>6 years) | Yes | Yes | No | Yes | N/A | 2014-08-11 | 173785 |
| Nyda | dimethicone | G. Pohl-Boskamp GMBH & CO KG | No | Pediculicide | Yes (>2 years) | Yes | Yes | Yes | N/A | Yes | 2012-09-11 | 156818 |
| Olmetec | olmesartan medoxomil | Schering-Plough Canada Inc. (now Merck Canada Inc.) | Yes | Angiotensin II AT1 Receptor Blocker | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2013-11-05 | 167656 |
| Omnaris | ciclesonide | Nycomed Canada Inc. (now Takeda Canada Inc.) | Yes | Corticosteroid for nasal use | Yes (>12 years) | Yes | Yes | Yes | Yes | Yes | 2013-01-02 | 160828 |
| Omnaris HFA | ciclesonide | Nycomed Canada Inc. (now Takeda Canada Inc.) | Yes | Corticosteroid for nasal use | Yes (>12 years) | Yes | Yes | Yes | No | Yes | 2014-02-10 | 170760 |
| Optimark | gadoverset amide | Mallinckrodt Canada ULC | No | Paramagnetic, intravascular, contrast agent for magnetic resonance imaging (MRI) | No | Yes | Yes | Yes | Yes | Yes | 2013-12-19 | 169672 |
| Posanol | posaconazole | Schering-Plough Canada Inc. (now Merck Canada Inc.) | Yes | Antifungal Agent | Yes (>13 years) | Yes | Yes | No | Yes | Yes | 2014-05-01 | 164946 |
| Prezista | darunavir ethanolate | Janssen-Ortho Inc. | Yes | Human Immuno-deficiency Virus (HIV) Protease Inhibitor | Yes (>3 years) |
Yes | Yes | Yes | Yes | Yes | 2014-05-30 | 173182 |
| Prinivil | lisinopril | Merck Frosst Canada LTD | No | Angiotensin-Converting Enzyme Inhibitor | Yes (>6 years) | Yes | Yes | Yes | Yes | N/A | 2013-06-13 | 163338 |
| Prograf | tacrolimus | Astellas Pharma Canada, Inc. | No | Immuno-suppressant | Yes (organ rejection) | Yes | Yes | No | Yes | Yes | 2013-09-26 | 166001 |
| Protopic | tacrolimus | Astellas Pharma Canada, Inc. | No | Topical Calcineurin Inhibitor | Yes (>2 years) | Yes | Yes | Yes | Yes | Yes | 2011-10-11 | 148894 |
| Resotran | prucalopride succinate | Janssen Inc. | No | Prokinetic agent | No | No | No | No | Yes | No | 2012-06-26 | 154828 |
| Retrovir (AZT) | zidovudine | Viiv Healthcare ULC | No | Antiretroviral Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2014-05-21 | 171617 |
| Reyataz | atazanavir sulfate | Bristol-Myers Squibb Canada | No | Azapeptide Inhibitor of HIV-1 Protease | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2013-09-25 | 165898 |
| Rivotril | clonazepam | Hoffmann-La Roche Limited | No | Anticonvulsant | Yes (>5 years) | Yes | Yes | Yes | Yes | N/A | 2013-06-21 | 163401 |
| Sabril | vigabatrin | Lundbeck | No | Antiepileptic | Yes | Yes | Yes | Yes | Yes | Yes | 2012-04-20 | 151945 |
| Saphris | asenapine maleate | Merck Canada Inc. | Yes | Antipsychotic | No | No | Yes | Yes | Yes | No | 2013-05-31 | 162826 |
| Sebivo | telbivudine | Novartis Pharmaceuticals Canada Inc. | No | Antiviral Agent | Yes (>16 years) | Yes | Yes | No | No | Yes | 2012-12-20 | 153455 |
| Silenor | Doxepin | Paladin Labs Inc. | No | Hypnotic | No | No | Yes | No | No | No | 2012-12-07 | 152398 |
| Smoflipid | fish oil, olive oil, soybean oil, medium-chain triglycerides | Fresenius Kabi Canada A division of Calea LTD | No | Lipid emulsion for intravenous nutrition | No | No | No | No | Yes | No | 2012-12-04 | 152134 |
| Suprane | desflurane | Baxter Corporation | No | Inhalation Anesthetic | Yes (>2 years) | Yes | Yes | Yes | Yes | Yes | 2013-03-13 | 160822 |
| Sustiva | efavirenz | Bristol-Myers Squibb Canada | No | Antiretroviral Agent | Yes (>3 years or 13kg) | Yes | Yes | Yes | No | No | 2013-09-23 | 165789 |
| Tactupump | benzoyl peroxide, adapalene | Galderma Canada INC | No | Acne Therapy | Yes (>9 years) | Yes | Yes | Yes | No | Yes | 2014-05-26 | 147466 |
| Tamiflu | oseltamivir | Hoffmann-La Roche Ltd. | No | Antiviral Agent | Yes (>1 year) | Yes | Yes | Yes | Yes | Yes | 2012-06-12 | 155227 |
| Tegretol | carbamazepine | Novartis Pharmaceuticals Canada Inc. | No | Anticonvulsant | Yes (>6 years for epilepsy) | Yes | Yes | No | Yes | No | 2014-03-13 | 169748 |
| Tivicay | dolutegravir sodium | Viiv Healthcare ULC | Yes | Human immuno-deficiency virus integrase strand transfer inhibitor | Yes (>12 years and >40 kg) |
Yes | Yes | Yes | Yes | Yes | 2014-03-11 | 170424 |
| Tobi Podhaler | tobramycin | Novartis Pharmaceuticals Canada Inc. | No | Respiratory Antibiotic | Yes (>6 years) | Yes | Yes | Yes | Yes | Yes | 2014-01-22 | 169258 |
| Topamax | topiramate | Janssen Inc. | No | Antiepileptic | Yes (>6 years for monotherapy and >2 years for adjunctive therapy) | Yes | Yes | Yes | Yes | Yes | 2014-04-28 | 171722 |
| Torisel | temsirolimus | Wyeth Canada (now Pfizer Canada Inc.) | Yes | Antineoplastic Agent | No | No | Yes | No | No | No | 2014-01-06 | 168761 |
| Trileptal | oxcarbazepine | Novartis Pharmaceuticals Canada Inc. | No | Antiepileptic | Yes (>6 years) | Yes | Yes | Yes | Yes | Yes | 2013-07-15 | 162686 |
| Valium | diazepam | Hoffmann-La Roche Ltd. | No | Anxiolytic-sedative | Yes (>6 months) | Yes | Yes | Yes | Yes | N/A | 2013-06-26 | 163402 |
| VFEND | voriconazole | Pfizer Canada Inc. | No | Antifungal Agent | Yes (>12 years) | Yes | Yes | Yes | Yes | Yes | 2013-11-08 | 169466 |
| Vimpat | lacosamide | UCB Canada Inc | No | Antiepileptic Agent | No | No | Yes | No | No | Yes | 2014-06-02 | 172700 |
| Vyvanse | lisdexamfetamine dimesylate | Shire Canada Inc. | Yes | Central Nervous System Stimulant | Yes (>6 years) |
Yes | Yes | Yes | Yes | Yes | 2014-01-17 | 170241 |
| Zeldox | ziprasidone hydrochloride monohydrate | Pfizer Canada Inc. | Yes | Antipsychotic Agent | No | No | Yes | Yes | Yes | No | 2013-05-01 | 161912 |
| Zemuron | rocuronium bromide | Schering-Plough Canada Inc. (now Merck Canada Inc.) | No | Non-depolarizing Skeletal Neuromuscular Blocking Agent | Yes | Yes | Yes | Yes | Yes | Yes | 2012-08-07 | 153746 |
| Zmax SR | azithromycin dihydrate | Pfizer Canada Inc. | No | Antibacterial Agent | No | No | Yes | Yes | No | Yes | 2014-06-27 | 173319 |
| Zocor | simvastatin | Merck Frosst Canada LTD | No | Lipid Metabolism Regulator | Yes (>10 years) with HeFH | Yes | Yes | Yes | No | Yes | 2014-02-21 | 170366 |
| Zomig, Zomig Rapimelt, Zomig Nasal Spray | zolmitriptan | Astrazeneca Canada Inc | No | Migraine Therapy | No | No | Yes | Yes | Yes | Yes | 2012-11-01 | 158295 |
| Zonalon Cream 5% | doxepin hydrochloride | Valeant Canada LP | No | Topical antipruritic | Yes (>12 years) | Yes | No | No | No | N/A | 2013-03-19 | 162602 |
Page details
- Date modified: